We’re Taking the CDC’s Draft Review of ME/CFS Diagnosis and Treatment to Congress

In 2018, the Centers for Disease Control (CDC) announced it was soliciting bids to create evidence-based treatment guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In 2019, the CDC announced a contract with the Pacific Northwest Evidence-Based Practice Center (EPC). The draft of this work, a Draft Systematic Evidence Review, was shared with the public for the […]

Read More

10 ME/CFS Organizations Join Solve M.E.’s Letter to Congress Recommending Priorities for Federal COVID-19 Relief Package

Last month, Solve M.E. identified yet another COVID-19 relief package funding opportunity for ME/CFS and worked with our friends on Capitol Hill to outline additional federal post-viral research and medical education investments. Ten other ME/CFS organizations joined Solve M.E.’s efforts to urge Congress to consider additional priorities for the upcoming federal 2021 COVID-19 relief package […]

Read More

ME/CFS Federal Funding: What We Know So Far

Thank you for your patience and for standing with Solve M.E. and our advocacy partners during a particularly turbulent year. Despite unprecedented obstacles, we accomplished victories and produced dollars for ME/CFS research. Though the future of ME/CFS funding in Congress remains uncertain, here’s what we know for sure: We Broke Records for Advocacy Day Despite […]

Read More

Winning and Waiting: A Federal Funding Update for ME/CFS

What you Need to Know: The Senate Appropriations Committee included our ME/CFS Advocacy Day request for Defense. If approved in the final budget, ME/CFS will be an eligible topic area for the Peer-Reviewed Medical Research Program (PRMRP), which is funded at $350 million next year. If the combined Senate and House bills pass, ME/CFS researchers could apply for […]

Read More